Correction Regarding Author Contributions
Background
Accurate author contributions are essential for maintaining the integrity of scientific literature. Corrections to authorship ensure proper attribution and transparency in research.
Data Highlights
No numerical or trial data is presented in this correction notice.
Key Findings
- Dr. Upendra Kaul did not obtain funding for the study on antiplatelet therapy.
- The correction will be reflected in the digital edition of the manuscript.
- Accurate authorship is crucial for scientific integrity.
- Corrections in published articles are necessary to maintain transparency.
Clinical Implications
Clinicians should be aware of the importance of accurate author contributions in research publications. This ensures that credit is appropriately assigned and that the research community can trust the integrity of published findings.
Conclusion
The correction serves as a reminder of the importance of accurate authorship in scientific publications. Maintaining transparency in research is vital for the credibility of scientific literature.
Related Resources & Content
- JAMA Cardiology, 2026 -- Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
- Journal of Medical Internet Research (JMIR) — Correction: Enhancing LGBTQ+ Inclusivity in an AI-Powered Sexual Health Chatbot: User-Centered Design Approach Through a Nonprofit and Academic Partnership
- Erratum: A Comparative Analysis of Hyperspectral Imaging Versus Fluorescence Angiography in Assessing Transection Margins During Colorectal Resections
- JMIR Medical Informatics — Correction: Automated ICD-10–Anchored Classification of Primary Care Text Data: Development and Evaluation of a Custom Multilabel Classifier
- Erratum: Utilizing XGBoost for Predicting Pathologic Complete Response in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Treatment
- 2025 Guideline for Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
- Scholars@Duke publication: Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
